BioCentury
ARTICLE | Distillery Therapeutics

Targeted Bcl-XL degrader identified to treat ALL, TNBC and SCLC

January 30, 2020 11:12 PM GMT
Updated on Jan 31, 2020 at 6:57 AM GMT
Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article